Volume 15, Number 4—April 2009
The Amazon Region
Oral Transmission of Chagas Disease by Consumption of Açaí Palm Fruit, Brazil
Highlight and copy the desired format.
|EID||Nóbrega AA, Garcia MH, Tatto E, Obara MT, Costa E, Sobel J, et al. Oral Transmission of Chagas Disease by Consumption of Açaí Palm Fruit, Brazil. Emerg Infect Dis. 2009;15(4):653-655. https://dx.doi.org/10.3201/eid1504.081450|
|AMA||Nóbrega AA, Garcia MH, Tatto E, et al. Oral Transmission of Chagas Disease by Consumption of Açaí Palm Fruit, Brazil. Emerging Infectious Diseases. 2009;15(4):653-655. doi:10.3201/eid1504.081450.|
|APA||Nóbrega, A. A., Garcia, M. H., Tatto, E., Obara, M. T., Costa, E., Sobel, J....Araujo, W. N. (2009). Oral Transmission of Chagas Disease by Consumption of Açaí Palm Fruit, Brazil. Emerging Infectious Diseases, 15(4), 653-655. https://dx.doi.org/10.3201/eid1504.081450.|
In 2006, a total of 178 cases of acute Chagas disease were reported from the Amazonian state of Pará, Brazil. Eleven occurred in Barcarena and were confirmed by visualization of parasites on blood smears. Using cohort and case–control studies, we implicated oral transmission by consumption of açaí palm fruit.
Chagas disease (American trypanosomiasis) chronically infects ≈10 million persons in Latin America (1). The etiologic agent is Trypanosoma cruzi, which is transmitted by bloodsucking triatomine insects. Other modes of transmission are transfusional, congenital, and oral (foodborne) (2). Oral transmission occurs by consumption of foods contaminated with triatomines or their feces or by consumption of raw meat from infected mammalian sylvatic hosts (3). The precise stage of food handling at which contamination occurs is unknown. The first outbreak of orally transmitted Chagas disease in Brazil was reported in 1965 (4). Two outbreaks were associated with consumption of sugar cane juice (5,6). In these outbreaks, the incubation period was ≈22 days, compared with 4–15 days for vectorial transmission and 30–40 days for transfusional transmission (7).
Chagas disease has not been considered endemic in the Brazilian Amazon region. The first Amazonian outbreak of acute Chagas disease was reported in 1968; oral transmission was suspected (8). During 1968–2005, a total of 437 cases of acute Chagas disease were reported in this region. Of these cases, 311 were related to 62 outbreaks in which the suspected mode of transmission was consumption of açaí (9).
Açaí is the fruit of a palm of the family Aracaceae (Figure 1, panel A); it is crushed to produce a paste or beverage. Most of the Amazonian population consumes açaí juice daily. Contamination is believed to be caused by triatomine stools on the fruit or insects inadvertently crushed during processing (10). There are no reports of collection of açaí for laboratory testing during an outbreak of acute Chagas disease. Because outbreaks with high attack rates occur in small groups whose members all consume the same foods, açaí has not been epidemiologically implicated in transmission of this disease.
During January–November 2006, a total of 178 cases of acute Chagas disease were reported in Pará State, Brazil, in the Amazon basin (Ministry of Health, unpub. data). Eleven of these cases occurred in Barcarena (population 63,268) (11) (Figure 1, panel B). All patients had symptom onset in September and October. Of the 11 case-patients, 5 were staff members at a health post who shared a meal at a staff meeting on September 15. We attempted to identify risk factors for illness.
We conducted a retrospective cohort study of staff members at the health post who participated in the meeting on September 15. A case-patient was any person who participated in the meeting and had a positive direct parasitologic examination result for T. cruzi or positive serologic results and clinical evidence of acute Chagas disease. A non-case was any person who participated in the meeting and had negative test results for T. cruzi. We also conducted a 1:3 case–control study (11 case-patients and 34 controls matched by sex and age) that included patients with laboratory-confirmed cases from Barcarena. A case-patient was any person in whom during September 1–October 15 T. cruzi was found by direct parasitologic examination, irrespective of signs or symptoms of disease, or who had positive serologic results and clinical evidence of disease. This interval was based on date of symptom onset of the first and last case-patient and a reported incubation period of 3–22 days for orally transmitted disease. Controls were age- and sex-matched residents of case-patient neighborhoods who had negative serologic results for T. cruzi.
Parasitologic examinations were conducted for case-patients by using quantitative buffy coat test, thick blood smear, or buffy coat test (the latter 2 tests included Giemsa staining). Serologic tests were conducted by using indirect hemagglutination test, ELISA, or indirect immunofluorescent test. An immunoglobulin (Ig) M titer >40 was considered positive. Controls had nonreactive IgM and IgG titers. We ruled out leishmaniasis in all persons with positive serologic results for T. cruzi by using an immunofluorescent test for IgM to Leishmania spp. (12).
We conducted an entomologic investigation during December 11–16, 2006, at the homes of 5 case-patients and in forested areas near the homes of 2 case-patients; at the commercial establishment where açaí consumed by the case-patients linked to the health post was prepared and served; at an açaí juice production and sale establishment reported to be frequented by other case-patients; and at the river dock market where açaí delivered to Barcarena is unloaded. At this market, we searched baskets used to transport açaí in river boats. We applied an insect-displacing compound (piridine; Pirisa, Taquara, Brazil) to the interior and exterior of buildings at investigation sites and placed traps (13) to obtain triatomines.
Data were analyzed by using Epi Info version 6.04d (Centers for Disease Control and Prevention, Atlanta, GA, USA). We measured relative risk in the cohort study and matched odds ratios in the matched case–control study, with 95% confidence intervals and α = 5%. Fisher exact, McNemar, Mantel-Haenszel, and Kruskall-Wallis tests were used as needed. Study power (1 – β) was 5%.
All case-patients had positive results for T. cruzi by direct examination of blood (Figure 2). Nine (82%) patients were female; median age was 39 years (range 7–70 years). Eight (73%) patients resided in urban areas, 7 (64%) in brick dwellings, and 3 (27%) in mixed brick and wooden dwellings. All patients denied having had blood transfusions or organ transplants, having slept in rural or sylvatic areas, and having been bitten by triatomines.
The epidemic curve for the 11 patients is shown in Figure 1, panel C. Main signs and symptoms were fever, weakness, facial edema, myalgia, arthralgia, and peripheral edema (Table 1). No deaths occurred, and median time from symptom onset to treatment initiation was 22 days.
The cohort consisted of 12 persons who attended the staff meeting. Of these persons, 6 shared a meal, 5 (83%) of whom were case-patients. The remaining persons were seronegative for T. cruzi. Exposures associated with infection were consumption of thick açaí paste and drinking açaí juice at the health post; consumption of chilled açaí was protective (Table 2). This shared meal was the only common exposure among cohort members. No other foods consumed at the meal were associated with illness (Table 2). Among exposures tested, drinking açaí juice on September 15 and at the health post were significantly associated with illness (p<0.02 and p<0.001, respectively; matched odds ratio not determined). Other exposures were not associated with illness. No triatomine insects were identified at any sites of the entomologic investigation.
Our study findings implicated açaí in an outbreak of acute Chagas disease. Oral transmission of this disease in the Amazon region has been reported since the 1960s. Açaí has long been the principal suspected food vehicle, but characteristics of outbreaks, small groups with universal exposure and high attack rates, have precluded epidemiologic implication of this food. There are no reports of timely collection of açaí for laboratory testing in an outbreak.
In this outbreak, vectorborne, transfusional, transplant-associated, and transplacental transmission were excluded. Incubation periods of cohort case-patients were compatible with those of previous reports. A shared meal was the only event linking case-patients, and cohort and case–control studies demonstrated an association between açaí consumption at this meal and infection. These findings indicate an outbreak of orally transmitted disease from contaminated açaí.
Limitations of this study are possible recall bias caused by delay between illness and investigation and failure to collect food samples for testing. Studies are needed to determine viability of T. cruzi in açaí, along with the tree-to-bowl continuum of açaí, to identify sources of contamination. Because açaí is a major dietary component in the Amazon region and a component of the local economy, identifying practical prevention measures is essential.
Ms Nóbrega is supervisor of the Field Epidemiology Training Program of the Brazilian Ministry of Health in Brasília, Brazil. Her research interests include the epidemiology of infectious diseases and outbreak investigations.
- Bilate AM, Cunha-Net E. Chagas disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop Sao Paulo. 2008;50:67–74.
- Amato Neto V, Lopes M, Umezawa ES, Aveiro Ruocco MS, Dias JC. Outras formas de transmissão do Trypanosoma cruzi. Revista de Patologia Tropical. 2000;29(Suppl):115–29.
- Dias JC. Notas sobre o Trypanosoma cruzi e suas características bio-ecológicas, como agente de enfermidades transmitidas por alimentos. Rev Soc Bras Med Trop. 2006;39:370–5.
- da Silva NN, Clausell DT, Nóbilis H, de Mello AL, Ossanai J, Rapone T, Epidemic outbreak of Chagas disease probably due to oral contamination [in Portuguese]. Rev Inst Med Trop Sao Paulo. 1968;10:265–76.
- Shikanai-Yasuda MA, Marcondes CB, Guedes LA, Siqueira GS, Barone AA, Dias JC, Possible oral transmission of acute Chagas disease in Brazil. Rev Inst Med Trop Sao Paulo. 1991;33:351–7.
- Tatto E, Menezes JA, Kitagawa BY, Freitas DR, Dimech GS, Wada MY, Acute Chagas disease (ACD) outbreak related to sugar cane drunk in Santa Catarina State, south Brasil. In: Abstracts of the 56th Meeting of the American Society of Tropical Medicine and Hygiene; 2007 Nov 4–8; Philadelphia. Philadelphia: The Society; 2007. Abstract 997.
- Brasil Ministério da Saúde. Secretaria de Vigilância em Saúde. Doença de Chagas aguda: manual prático de subsídio à notificação obrigatória no Sinan. Brasília: Ministério da Saúde, Sistema de Informação de Agravos de Notificação (Sinan); 2004.
- Shaw J, Lainson R, Fraiha H. Epidemiology of the first autochthonous case of Chagas’ disease recorded in Belém, Pará, Brazil [in Portuguese]. Rev Saude Publica. 1969;3:153–7.
- Valente SA, Valente VC, Pinto AY. Epidemiologia e transmissão oral da doença de Chagas na Amazônia brasileira. In: Informe de la consulta técnica em epidemiologia, prevencion y manejo de la transmision de la enfermidad de chagas como enfermidad transmitida por alimentos (ETA). Washington: Organizacion Panamericana de La Salud/Organizacion Mundial de La Salud; 2006. p. 21–6.
- Valente SA, Valente VC, Fraiha Neto H. Transmissão da doença de Chagas: como estamos? Rev Soc Bras Med Trop. 1999;32(Suppl II):51–5.
- Instituto Brasileiro de Geografia e Estatística [cited 2009 Jan 6]. Available from http://www.ibge.gov.br
- Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Doenças infecciosas e parasitarias: guia de bolso. Brasília: Ministério da Saúde; 2005.
- Noireau F, Abad-Franch F, Valente SA, Dias-Lima A, Lopes CM, Cunha V, Trapping triatominae in silvatic habitats. Mem Inst Oswaldo Cruz. 2002;97:61–3.
TablesCite This Article
- Page created: December 10, 2010
- Page last updated: December 10, 2010
- Page last reviewed: December 10, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)